Morgan Stanley Precigen, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Precigen, Inc. stock. As of the latest transaction made, Morgan Stanley holds 1,215,350 shares of PGEN stock, worth $1.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,215,350

Previous 1,007,304 20.65%

Holding current value

$1.02 Million

Previous $1.59 Million 27.47%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.91 - $1.88 $189,321 - $391,126	208,046 Added 20.65%	1,215,350 $1.15 Million
Q2 2024 Oct 17, 2024	SELL	$1.27 - $1.75 $71,150 - $98,042	-56,024 Reduced 5.27%	1,007,304 $1.59 Million
Q2 2024 Aug 14, 2024	SELL	$1.27 - $1.75 $71,150 - $98,042	-56,024 Reduced 5.27%	1,007,304 $1.59 Million
Q1 2024 Oct 17, 2024	BUY	$1.21 - $1.75 $67,789 - $98,042	56,024 Added 5.56%	1,063,328 $1.54 Million
Q1 2024 Aug 16, 2024	SELL	$1.21 - $1.75 $243,187 - $351,716	-200,981 Reduced 15.9%	1,063,328 $1.54 Million
Q1 2024 May 15, 2024	SELL	$1.21 - $1.75 $243,187 - $351,716	-200,981 Reduced 15.9%	1,063,328 $1.54 Million
Q4 2023 Aug 16, 2024	BUY	$0.89 - $1.41 $228,734 - $362,377	257,005 Added 25.51%	1,264,309 $1.69 Million
Q4 2023 Feb 13, 2024	BUY	$0.89 - $1.41 $259,755 - $411,522	291,860 Added 30.01%	1,264,309 $1.69 Million
Q3 2023 Nov 15, 2023	BUY	$1.08 - $1.85 $34,656 - $59,364	32,089 Added 3.41%	972,449 $1.38 Million
Q2 2023 Aug 14, 2023	BUY	$0.96 - $1.4 $26,986 - $39,355	28,111 Added 3.08%	940,360 $1.08 Million
Q1 2023 May 15, 2023	BUY	$0.88 - $2.19 $71,163 - $177,100	80,868 Added 9.73%	912,249 $966,000
Q4 2022 Feb 14, 2023	SELL	$1.27 - $2.26 $55,462 - $98,696	-43,671 Reduced 4.99%	831,381 $1.26 Million
Q3 2022 Nov 14, 2022	SELL	$1.41 - $2.79 $38,219 - $75,625	-27,106 Reduced 3.0%	875,052 $1.86 Million
Q2 2022 Oct 27, 2022	SELL	$1.15 - $2.53 $276,603 - $608,528	-240,525 Reduced 21.05%	902,158 $1.21 Million
Q2 2022 Aug 15, 2022	SELL	$1.15 - $2.53 $276,603 - $608,528	-240,525 Reduced 21.05%	902,158 $1.21 Million
Q1 2022 Oct 27, 2022	BUY	$1.91 - $3.98 $459,402 - $957,289	240,525 Added 26.66%	1,142,683 $2.41 Million
Q1 2022 May 13, 2022	BUY	$1.91 - $3.98 $336,767 - $701,745	176,318 Added 18.25%	1,142,683 $2.41 Million
Q4 2021 Feb 14, 2022	BUY	$3.53 - $5.5 $146,131 - $227,683	41,397 Added 4.48%	966,365 $3.59 Million
Q3 2021 Nov 15, 2021	BUY	$4.99 - $6.55 $4.62 Million - $6.06 Million	924,968 New	924,968 $4.62 Million

Others Institutions Holding PGEN

# of Institutions

143

Shares Held

159M

Call Options Held

232K

Put Options Held

69K

View Full List

About PRECIGEN, INC.

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $175M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

More about PGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account